CardiaCare is a clinical stage Digital Therapeutic company has developed the world’s first closed loop wearable for non-invasive treatment of Atrial Fibrillation and other cardiac arrhythmias.

Providing a non-invasive, nerve stimulation treatment with continuous monitoring and AI based alerts capabilities, CardiaCare’s device is the only platform that enables complete remote patient management and personalized treatment.

The device stems from many years of treatment of real-world patients and integrates know how and innovation from diverse disciplines.

CardiaCare has a functional prototype and successfully completed a FIM study.

Multi-National RCT's are currently underway.